用巴里西提尼布和窄带紫外线B治疗活跃非细分性白的联合治疗:一项回顾性受控研究
Bin Zhou1,2, Jiachen Gui2,3, Tao Wang2,4
1Graduate School, Hebei North University, Zhangjiakou, People's Republic of China.
Clinical, cosmetic and investigational dermatology
|December 26, 2024
概括
用巴里西提尼布和窄带UV-B (NB-UVB) 进行的联合治疗对活跃非细分性白风 (NSV) 显示出有前途的结果. 这种治疗方法耐受性良好,有效改善皮肤色素脱落.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- Vitiligo 是一种慢性自身免疫性皮肤疾病,其特征是黑色素细胞的损失.
- 巴里西提尼布是一种简氏激酶 (JAK) 抑制剂,在白风治疗中已经证明了初步的疗效.
- 活跃非细分性白风 (NSV) 需要有效的治疗策略.
研究的目的:
- 评估结合巴里西提尼布与狭带UV-B (NB-UVB) 光疗对NSV的疗效和耐受性.
- 为了比较这种组合治疗与接受NB-UVB和口服迷你脉冲甲基普雷迪尼索隆的对照组.
- 评估治疗结果和治疗后复发率.
主要方法:
- 一组组合组 (n=52) 接受了巴里西提尼布加NB-UVB.
- 一组对照组 (n=49) 接受了口服迷你脉冲甲基普雷迪尼索隆加NB-UVB.
- 在6个月的时间内评估了疗效,并对复发率进行了随访.
主要成果:
- 组合组从第一个月开始显著降低了VASI分数.
- 综合反应率 (ORR) 在组合组 (86.5%) 与对照组 (67.3%) 在第六个月更高.
- 组合组的IFN-γ和CXCL10血清水平显著下降;在治疗后6个月内,在组之间没有观察到复发率的显著差异.
- 副作用是轻微的,在组合组中的少数患者中报告了皮肤和红疹.
结论:
- 与巴里西提尼布和NB-UVB的联合治疗是对NSV的有希望的治疗方法.
- 治疗方案耐受性良好,没有报告严重不良事件.
- 这些发现支持进行更大规模的临床试验,以进一步验证这种治疗方法.
相关概念视频
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
84
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
84


